APGE
Price
$40.59
Change
+$0.41 (+1.02%)
Updated
May 22, 04:40 PM (EDT)
Capitalization
2.34B
CTMX
Price
$2.12
Change
+$0.08 (+3.92%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
321.39M
77 days until earnings call
Interact to see
Advertisement

APGE vs CTMX

Header iconAPGE vs CTMX Comparison
Open Charts APGE vs CTMXBanner chart's image
Apogee Therapeutics
Price$40.59
Change+$0.41 (+1.02%)
Volume$3.75K
Capitalization2.34B
CytomX Therapeutics
Price$2.12
Change+$0.08 (+3.92%)
Volume$17.07K
Capitalization321.39M
APGE vs CTMX Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. CTMX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Buy and CTMX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (APGE: $40.18 vs. CTMX: $2.04)
Brand notoriety: APGE and CTMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 63% vs. CTMX: 53%
Market capitalization -- APGE: $2.34B vs. CTMX: $321.39M
APGE [@Biotechnology] is valued at $2.34B. CTMX’s [@Biotechnology] market capitalization is $321.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileCTMX’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • CTMX’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than CTMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 6 TA indicator(s) are bullish while CTMX’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 6 bullish, 2 bearish.
  • CTMX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, APGE is a better buy in the short-term than CTMX.

Price Growth

APGE (@Biotechnology) experienced а +0.83% price change this week, while CTMX (@Biotechnology) price change was -14.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.57%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was -2.23%.

Reported Earning Dates

APGE is expected to report earnings on May 12, 2025.

CTMX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.34B) has a higher market cap than CTMX($321M). CTMX YTD gains are higher at: 98.058 vs. APGE (-11.302). CTMX has higher annual earnings (EBITDA): 26.8M vs. APGE (-216.68M). APGE has more cash in the bank: 521M vs. CTMX (101M). CTMX has less debt than APGE: CTMX (9.39M) vs APGE (11.8M). CTMX has higher revenues than APGE: CTMX (138M) vs APGE (0).
APGECTMXAPGE / CTMX
Capitalization2.34B321M730%
EBITDA-216.68M26.8M-809%
Gain YTD-11.30298.058-12%
P/E RatioN/A4.25-
Revenue0138M-
Total Cash521M101M516%
Total Debt11.8M9.39M126%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGECTMX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 7 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 4 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X109678.0800002886.992200
+2.70%
Bitcoin cryptocurrency
GME28.05-0.46
-1.61%
GameStop Corp
SPY582.86-9.99
-1.69%
SPDR® S&P 500® ETF
AAPL202.09-4.77
-2.31%
Apple
TSLA334.62-9.20
-2.68%
Tesla

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-0.40%
SYRE - APGE
53%
Loosely correlated
-4.03%
CRNX - APGE
52%
Loosely correlated
-4.53%
KYMR - APGE
52%
Loosely correlated
-4.17%
ATXS - APGE
52%
Loosely correlated
-8.62%
ELVN - APGE
52%
Loosely correlated
-2.59%
More

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with REGN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then REGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-0.97%
REGN - CTMX
38%
Loosely correlated
-1.65%
BCAB - CTMX
37%
Loosely correlated
-2.40%
CRNX - CTMX
37%
Loosely correlated
-4.53%
NKTR - CTMX
37%
Loosely correlated
-7.95%
APGE - CTMX
35%
Loosely correlated
-0.40%
More